{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:44:20Z","timestamp":1774413860427,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1159\/000152000","type":"journal-article","created":{"date-parts":[[2008,9,4]],"date-time":"2008-09-04T03:16:45Z","timestamp":1220498205000},"page":"510-519","source":"Crossref","is-referenced-by-count":72,"title":["Chromogranin A Levels in Diagnosis, Treatment and Follow-Up of 42 Patients with Non-Functioning Pancreatic Endocrine Tumours"],"prefix":"10.1016","volume":"8","author":[{"given":"G.C.","family":"Nikou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Marinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Thomakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Sanzanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Moulakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1159\/000152000_bib1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.bpg.2005.06.002","article-title":"Endocrine tumours of the pancreas","volume":"19","author":"Oberg","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1159\/000152000_bib2","first-page":"520","article-title":"Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine","volume":"6","author":"Goh","year":"2006","journal-title":"Neoplasm"},{"key":"10.1159\/000152000_bib3","series-title":"Histological Typing of Endocrine Tumours, ed 2: WHO International Histological Classification of Tumours","author":"Solcia","year":"2000"},{"key":"10.1159\/000152000_bib4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1677\/erc.1.01017","article-title":"Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization","volume":"12","author":"Panzuto","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1159\/000152000_bib5","first-page":"1540","article-title":"Pancreatic endocrine tumours","volume":"2","author":"Alexander","year":"2005"},{"key":"10.1159\/000152000_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/eje.0.1480039","article-title":"Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumours or multiple endocrine neoplasia type 1","volume":"148","author":"Peracchi","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1159\/000152000_bib7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMra021405","article-title":"The chromogranin secretogranin family","volume":"348","author":"Taupenot","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1159\/000152000_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.2005.01.013","article-title":"Detection of liver metastases from endocrine tumours: a prospective comparison of somatostatin receptor scintigraphy, computed tomography and magnetic resonance imaging","volume":"23","author":"Dromain","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1159\/000152000_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000090026","article-title":"Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival","volume":"6","author":"Rodallec","year":"2006","journal-title":"Pancreatology"},{"key":"10.1159\/000152000_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.beem.2004.11.016","article-title":"Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours","volume":"19","author":"Oberg","year":"2005","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1159\/000152000_bib11","first-page":"731","article-title":"Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues","volume":"52","author":"Nikou","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"10.1159\/000152000_bib12","first-page":"312","article-title":"Somatostatin-receptor imaging in the diagnosis and management of gut endocrine tumours","volume":"8","author":"Nikou","year":"1995","journal-title":"Hell J Gastroenterol"},{"key":"10.1159\/000152000_bib13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.1994.tb17292.x","article-title":"Endosonography of neuroendocrine tumours of the stomach, duodenum and pancreas","volume":"733","author":"Zimmer","year":"1994","journal-title":"Ann NY Acad Sci"},{"issue":"suppl 1","key":"10.1159\/000152000_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000051850","article-title":"Molecular genetics of neuroendocrine tumours","volume":"62","author":"Calender","year":"2000","journal-title":"Digestion"},{"key":"10.1159\/000152000_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000079616","article-title":"Hereditary pancreatic endocrine tumours","volume":"4","author":"Alexakis","year":"2004","journal-title":"Pancreatology"},{"key":"10.1159\/000152000_bib16","series-title":"Pathology and Genetics of Tumours of Endocrine Organs: WHO Classification of Tumours","author":"DeLellis","year":"2004"},{"key":"10.1159\/000152000_bib17","series-title":"Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas","author":"Odze","year":"2004"},{"key":"10.1159\/000152000_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s002689900387","article-title":"Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumours: general recommendations by a consensus workshop","volume":"22","author":"Wiedenmann","year":"1998","journal-title":"World J Surg"},{"key":"10.1159\/000152000_bib19","first-page":"481","article-title":"Highly aggressive policy of hepatic resections for neuroendocrine liver metastases","volume":"47","author":"Grazi","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1159\/000152000_bib20","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1111\/j.1572-0241.2000.03210.x","article-title":"The antitumoural effect of the long-acting somatostatin analogue lanreotide in neuroendocrine tumours","volume":"95","author":"Ducreux","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1159\/000152000_bib21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/gut.38.3.430","article-title":"Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours","volume":"38","author":"Arnold","year":"1996","journal-title":"Gut"},{"key":"10.1159\/000152000_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00259-002-1023-y","article-title":"Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study","volume":"30","author":"Bodei","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1159\/000152000_bib23","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1200\/JCO.2005.08.066","article-title":"Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumours","volume":"23","author":"Kwekkeboom","year":"2005","journal-title":"J Clin Oncol"},{"issue":"suppl 1","key":"10.1159\/000152000_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000080747","article-title":"Chemotherapy for gastro-enteropancreatic neuroendocrine tumours","volume":"80","author":"O'Toole","year":"2004","journal-title":"Neuroendocrinology"},{"key":"10.1159\/000152000_bib25","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.20466","article-title":"A phase II trial of gemcitabine for metastatic neuroendocrine tumours","volume":"101","author":"Kulke","year":"2004","journal-title":"Cancer"},{"key":"10.1159\/000152000_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1081\/CNV-200029058","article-title":"A phase II study of docetaxel in patients with metastatic neuroendocrine tumours","volume":"22","author":"Kulke","year":"2004","journal-title":"Cancer Invest"},{"issue":"suppl 1","key":"10.1159\/000152000_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000051860","article-title":"Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours","volume":"62","author":"Rusniewski","year":"2000","journal-title":"Digestion"},{"key":"10.1159\/000152000_bib28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00268-002-6629-5","article-title":"Laparoscopic radiofrequency ablation of neuroendocrine liver metastases","volume":"26","author":"Berber","year":"2002","journal-title":"World J Surg"},{"key":"10.1159\/000152000_bib29","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/annonc\/mdi358","article-title":"Endocrine pancreatic tumours: factors correlated with survival","volume":"16","author":"Tomassetti","year":"2005","journal-title":"Ann Oncol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390308800634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390308800634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,26]],"date-time":"2018-12-26T04:56:16Z","timestamp":1545800176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390308800634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":29,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1424390308800634"],"URL":"https:\/\/doi.org\/10.1159\/000152000","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}